FXR−/− mice spontaneously develop hepatocellular carcinoma beyond 12 months of age, suggesting that FXR has a prominent function as a tumor suppressor against liver tumor formation [15], [16] but also against intestinal tumor formation [17], [18], [19]. This evidence concerns the gene NR1H4 and hepatocellular carcinoma.